Cleverage VentureCapital
VC Fund
Cleverage VentureCapital is a VC fund focused on Health Care and SaaS. Cleverage Venture Capital
- Total investments:
- 11
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries Cleverage VentureCapital invests in
Stages Cleverage VentureCapital invests in
Countries Cleverage VentureCapital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $154k–$1.7M
- Convertible Note
- $79k–$409k
Investment Focus
Industry
- Health Care 4 (36%)
- SaaS 2 (18%)
- Big Data 2 (18%)
- Analytics 2 (18%)
- Medical Device 2 (18%)
Stage
- Seed 5 (45%)
- Convertible Note 2 (18%)
- Pre-Seed 1 (9%)
- Venture - Series Unknown 1 (9%)
Country
- Romania 4 (36%)
- Czech Republic 1 (9%)
- The Netherlands 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Sergiu Negut
Co-Founder
|
Co-Founder | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Kardi Ai is a healthtech startup focused on long-term heart monitoring. With its smart wearable and AI-powered app, it provides a 6× higher chance of detecting heart rhythm disorders than current methods, covering 7 types of arrhythmias. Backed by MDR class IIa medical certification, it empowers people to protect their heart health while givingdoctors a reliable tool that saves time and improves patient care. | $1.3M / Seed / Apr 28, 2025 | ||
| Kardi Ai is a healthtech startup focused on long-term heart monitoring. With its smart wearable and AI-powered app, it provides a 6× higher chance of detecting heart rhythm disorders than current methods, covering 7 types of arrhythmias. Backed by MDR class IIa medical certification, it empowers people to protect their heart health while givingdoctors a reliable tool that saves time and improves patient care. | $1.7M / Seed / Nov 28, 2023 | ||
|
Synaptiq.io
|
When Artificial Intelligence meets Medical Analysis - we create software solutions based on AI for improving medical services. | $482.1K / Venture - Series Unknown / Apr 04, 2023 | |
| XVision is an automated x-ray analysis application that assists radiologists by providing accurate interpretations of medical images | $1.1M / Seed / Jan 31, 2022 | ||
| Medicai specializes in improving healthcare services by providing scalable and compliant medical imaging infrastructure. Medicai helps healthcare organizations (hospitals, clinics) collaborate easily and improve patient outcomes. The company developed a flexible medical imaging infrastructure that seamlessly integrates with any on-prem system(PACS), and provides secure, unified access to all medical data and an easy way to visualize it through the web and mobile portal for doctors and patients. The company's cloud infrastructure provides seamless backup and recovery capabilities, as well as extremely cost-effective long term storage (VNA). | $329K / Convertible Note / Oct 28, 2021 | ||
| Medicai specializes in improving healthcare services by providing scalable and compliant medical imaging infrastructure. Medicai helps healthcare organizations (hospitals, clinics) collaborate easily and improve patient outcomes. The company developed a flexible medical imaging infrastructure that seamlessly integrates with any on-prem system(PACS), and provides secure, unified access to all medical data and an easy way to visualize it through the web and mobile portal for doctors and patients. The company's cloud infrastructure provides seamless backup and recovery capabilities, as well as extremely cost-effective long term storage (VNA). | $408.9K / Convertible Note / Oct 28, 2021 | ||
| Upgrade Academy operates an online platform to help students reach their university goals. It provides course assistance, learning plans, and mentors. Upgrade Academy is based in London, United Kingdom. | $469.1K / Seed / Sep 20, 2021 | ||
| RepsMate is a conversation intelligence platform that integrates with existing telephony, chat, and email systems. By providing organizations with the tools to empower their agents, it ensures top-notch service in every interaction. RepsMate analyzes all customer interactions, identifying areas for improvement and transforming them into actionableinsights. This targeted approach helps address specific weaknesses in customer-facing departments, leading to more satisfied customers, increased operational efficiency and revenue growth. | $79.4K / Convertible Note / Jun 01, 2021 | ||
| SanoPass is a medical service providers to sell preventive medical packages to firms | $907.9K / Seed / Mar 20, 2021 | ||
| Oncochain is developing a real-world data platform in oncology to standardize, collect and aggregate anonymized data from patients who suffer from cancer. This creates the possibility to generate useful analytics that can orientate research for pharma companies and help healthcare providers deliver value-based care. Our proprietary method ofcollection is a web-based Oncology specific EHR that acts as a software platform creating operational data repositories for RWD studies. We greatly aid the informational flow between providers and upskill oncology professionals. We support research by reducing recruitment times in clinical trials and by creating the necessary framework for multi-centric studies design and implementation. Oncochain SaaS Analytics Tool offers much-needed RWD insights for clients like pharma companies and CROs. | $153.6K / Seed / Oct 12, 2020 | ||
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Cleverage VentureCapital invest in?
Cleverage VentureCapital invests primarily in Health Care, SaaS and Big Data startups, most often at Seed and Convertible Note stage. Most of the 11 investments tracked by Shizune back companies in Romania. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Cleverage VentureCapital's check size?
Cleverage VentureCapital typically joins rounds of $154k–$1.7M at Seed and $79k–$409k at Convertible Note. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Cleverage VentureCapital participates in.
How do I contact Cleverage VentureCapital?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cleverage VentureCapital?
The team at Cleverage VentureCapital includes Sergiu Negut (Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
